|
|
| Name |
Chen, Lieping |
| Location
|
Yale School of Medicine |
| Primary Field
|
Medical Genetics, Hematology and Oncology |
| Secondary Field
|
Immunology and Inflammation |
 Election Citation
|
|
Chen's findings enable the development of anti-PD-1/PD-L1 immunotherapies that have achieved sustained anti-tumor responses in patients with a variety of advanced cancers.
|
|
|
|
|
|